COMPA regimen

an intravenous chemotherapy regimen consisting of the above compounds

Also Known As:

IV-COMPA

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - COMPA regimen: 1
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - COMPA regimen: 1
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - COMPA regimen: 1
Inorganic Chemicals: 9
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthacenes
        Anthracyclines: 9423
        Daunorubicin: 2641
        Doxorubicin: 35390
        COMPA regimen: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        COMPA regimen: 1
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        COMPA regimen: 1
- Glycoconjugates: 1353
  - Glycopeptides: 1928
    - Bleomycin: 9833
      - Peplomycin: 343
        COMPA regimen: 1
Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Indole Alkaloids: 200
    - Secologanin Tryptamine Alkaloids: 81
      - Vinca Alkaloids: 463
        Vincristine: 9251
        COMPA regimen: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Glycopeptides: 1928
    - Bleomycin: 9833
      - Peplomycin: 343
        COMPA regimen: 1

Related Diseases

1.	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/01/1995 - "One course of IV-COMPA was delivered at 2-week intervals and consisted of 30 mg/m2 CDDP on day 4 and 5, 0.6 mg/m2 VCR (Oncovin) on day 1 and 2, 5 mg/m2 MTX on day 2 and 3, 5 mg/m2 PEP on day 1, 2 and 3, 20 mg/m2 ADM on day 4. A few patients received the same regimen without peplomycin called IV-COMA to avoid pulmonary fibrosis. "
2.	Neoplasms (Cancer) 06/01/1995 - "The clinical value of IV-COMPA chemotherapy was evaluated based on the results of 24 patients with urothelial cancers. " 06/01/1995 - "[Clinical results of IV-compa (cisplatin, vincristine, methotrexate, peplomycin and adriamycin) chemotherapy for advanced urothelial cancer]."
3.	Coma (Comas) 06/01/1995 - "One course of IV-COMPA was delivered at 2-week intervals and consisted of 30 mg/m2 CDDP on day 4 and 5, 0.6 mg/m2 VCR (Oncovin) on day 1 and 2, 5 mg/m2 MTX on day 2 and 3, 5 mg/m2 PEP on day 1, 2 and 3, 20 mg/m2 ADM on day 4. A few patients received the same regimen without peplomycin called IV-COMA to avoid pulmonary fibrosis. "
4.	Cadaver (Cadavers) 06/01/1995 - "These patients were treated with 2 or 3 corpses of postoperative IV-COMPA chemotherapy to improve prognosis. "

Related Drugs and Biologics

1.	Peplomycin
2.	Vincristine (Oncovin)
3.	Methotrexate (Mexate)
4.	Doxorubicin (Adriamycin)
5.	Cisplatin (Platino)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)